This specialty pharmaceutical company has seen a mixed track record when it comes to estimate revisions of 1 increase and 2 decreases over the last 30 days. Meanwhile, the Zacks Consensus Estimate has moved higher over the same period. This implies solid trading potential for the company. So make sure to keep an eye on this stock going forward to see if yesterday’s rally can turn into more strength down the road.
BioDelivery Sciences currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Investors interested in the bio-med/gene industry may consider Affymetrix Inc. (AFFX) which sports a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment